|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,031.00 GBX | 0.00% |
|
-0.34% | +11.32% |
| 03-13 | GSK and Amgen to add medicines to TrumpRx, Fox Business reports | RE |
| 03-13 | GSK plc Announces Expansion of AREXVY Approval to Adults Aged 18 to 49 Years for RSV Prevention | CI |
efdc1965ac7c7c01382173059.2K1P3QPEfcYakY0MRB8HwBhDqdMjRB7xYp0hw8vAWyw.vOc_mTOpD6VO2_1UKEdEuF07xIFoMHmBIfNFsKeQEB-Z6QWlaI4-tyLGyA~dcebbe62660f5d8ef5000a74a248f89e
- Stock Market
- Equities
- GSK Stock
- Charts GSK plc
- News Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















